Developer and manufacturer of sterile inhalation and 503B outsourcing medication.
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | THE VOGEL GROUP |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2025 | THE VOGEL GROUP |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2025 | THE VOGEL GROUP |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | |
| 2025 | THE VOGEL GROUP |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | |
| 2025 | THE VOGEL GROUP |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report (No Activity) |
— | |
| 2025 | THE VOGEL GROUP |
2nd Quarter (Apr 1 - June 30) AMENDED |
— | |
| 2023 | THE VOGEL GROUP |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Termination (No Activity) |
— | |
| 2023 | THE VOGEL GROUP |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report (No Activity) |
— | |
| 2022 | THE VOGEL GROUP |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2022 | THE VOGEL GROUP |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— |
| Firm | Filings | Expenses |
|---|---|---|
| THE VOGEL GROUP | 29 | — |
| Issue | Activities |
|---|---|
| Health Issues | 21 |
| Manufacturing | 15 |
| Pharmacy | 6 |
| Taxation/Internal Revenue Code | 1 |